E-cigarette, or Vaping, Product Use Associated Lung Injury with Hemosiderin-Laden Macrophages and Foamy Histiocytes
Aleksandr Kalininskiy(University of Rochester Medicine), Nicholas Nacca(Strong Memorial Hospital), Daniel P. Croft(University of Rochester), Serban A. Staicu(University of Rochester Medicine), Matthew McGraw(University of Rochester Medicine), Anne Marie Mattingly(University of Rochester)
Cited by 1
Related Papers
E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach
|The Lancet Respiratory Medicine|2019|256
The E-cigarette or Vaping Product Use–Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report
|Annals of the American Thoracic Society|2022|134
Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)
|Toxics|2020|82
Understanding the asthmatic response to an experimental rhinovirus infection: Exploring the effects of blocking IgE
|Journal of Allergy and Clinical Immunology|2020|47